Mannatech (NASDAQ:MTEX) and Canopy Growth (NASDAQ:CGC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation.
Valuation and Earnings
This table compares Mannatech and Canopy Growth's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Mannatech | $157.73 million | 0.24 | $3.29 million | N/A | N/A |
Canopy Growth | $297.34 million | 39.20 | $-993,370,000.00 | $1.32 | 23.49 |
Mannatech has higher earnings, but lower revenue than Canopy Growth.
Risk & Volatility
Mannatech has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 2.44, suggesting that its stock price is 144% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent ratings and target prices for Mannatech and Canopy Growth, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Mannatech | 0 | 0 | 0 | 0 | N/A |
Canopy Growth | 5 | 10 | 4 | 1 | 2.05 |
Canopy Growth has a consensus target price of $38.5667, suggesting a potential upside of 24.37%. Given Canopy Growth's higher probable upside, analysts plainly believe Canopy Growth is more favorable than Mannatech.
Profitability
This table compares Mannatech and Canopy Growth's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Mannatech | 5.04% | 28.69% | 11.99% |
Canopy Growth | -312.84% | -13.11% | -9.66% |
Insider & Institutional Ownership
15.0% of Mannatech shares are owned by institutional investors. Comparatively, 10.2% of Canopy Growth shares are owned by institutional investors. 45.8% of Mannatech shares are owned by insiders. Comparatively, 0.3% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
Mannatech beats Canopy Growth on 7 of the 13 factors compared between the two stocks.